EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target

Guorong Zhang, Hanzhi Yu, Jingjing Liu, Ge Dong, Zhigang Cai

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Guorong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, Chi…. Hauptthemen laut MEDLINE: Membrane Proteins, Immunotherapy, Neoplasms, Myeloid Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Experimental Hematology, Tianjin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsImmunotherapyNeoplasmsMyeloid CellsAnimalsHumansTumor MicroenvironmentMiceCD8-Positive T-LymphocytesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinMice, Inbred C57BLCell Line, TumorMacrophagesTumor-Associated Macrophages

Stichwörter der Autor:innen

CP: CancerCP: ImmunologyLRRC25cancer immunotherapymembrane proteintumor microenvironmenttumor-associated macrophages

Substanzen

Membrane ProteinsInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China; State Key Laboratory of Experimental Hematology, Tianjin Medical U…

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Experimental Hematology
  • Tianjin Medical University
  • Fudan University

Zitieren

APA

Zhang, G., Yu, H., Liu, J., Dong, G., & Cai, Z. (2025). Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115631

Vancouver

Zhang G, Yu H, Liu J, Dong G, Cai Z. Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115631

BibTeX
@article{Zhang2025,
  author = {Zhang, Guorong and Yu, Hanzhi and Liu, Jingjing and Dong, Ge and Cai, Zhigang},
  title = {Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115631}
}
Kostenlos starten →